Glezer Eli N.'s Form 4 filing
Singular Genomics Systems, Inc.OMIC · filed Nov 20, 2023
- Accession no.
- 0001209191-23-056069
- Filed
- Nov 20, 2023, 4:30 PM ET
- Trade date
- Nov 16, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $85.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glezer Eli N.CIK 0001859694 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Common Stock | PPurchaseAcquired | +200,000 | $0.4282F1 | +$85,640 | 4,570,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.4212 to $0.4299, inclusive. The reporting person undertakes to provide to Singular Genomics Systems, Inc., any security holder of Singular Genomics Systems, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.